Mylan Continues Busy Year With Perrigo Offer
This article was originally published in The Pink Sheet Daily
Executive Summary
Still integrating businesses gained from Abbott and Famy Care, Mylan proposes a $205-per-share bid for Perrigo, which itself just closed a $4.5 billion takeout of Omega Pharma.